Allmed Solutions Ltd (ALMD) - Total Liabilities
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has total liabilities worth ILA3.48 Million ILA (≈ $9.32K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Allmed Solutions Ltd asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Allmed Solutions Ltd - Total Liabilities Trend (2008–2025)
This chart illustrates how Allmed Solutions Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Allmed Solutions Ltd (ALMD) total assets.
Allmed Solutions Ltd Competitors by Total Liabilities
The table below lists competitors of Allmed Solutions Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Focus Dynamics Group Bhd
KLSE:0116
|
Malaysia | RM228.62 Million |
|
Magontec Ltd
AU:MGL
|
Australia | AU$26.01 Million |
|
Nyrstar NV
BR:NYR
|
Belgium | €20.26 Million |
|
Curanex Pharmaceuticals Inc Common Stock
NASDAQ:CURX
|
USA | $185.96K |
|
ECP Emerging Growth Ltd
AU:ECP
|
Australia | AU$10.43 Million |
|
Aqua Metals Inc
NASDAQ:AQMS
|
USA | $3.09 Million |
|
Fiberweb (India) Limited
NSE:FIBERWEB
|
India | Rs166.67 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Allmed Solutions Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Allmed Solutions Ltd balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 10.31 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Allmed Solutions Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Allmed Solutions Ltd (2008–2025)
The table below shows the annual total liabilities of Allmed Solutions Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ILA3.48 Million ≈ $9.32K |
+25.23% |
| 2024-12-31 | ILA2.77 Million ≈ $7.44K |
-13.15% |
| 2023-12-31 | ILA3.19 Million ≈ $8.57K |
-16.21% |
| 2022-12-31 | ILA3.81 Million ≈ $10.22K |
+53.56% |
| 2021-12-31 | ILA2.48 Million ≈ $6.66K |
-67.27% |
| 2020-12-31 | ILA7.59 Million ≈ $20.34K |
-28.59% |
| 2019-12-31 | ILA10.62 Million ≈ $28.49K |
+3.60% |
| 2018-12-31 | ILA10.26 Million ≈ $27.50K |
-21.69% |
| 2017-12-31 | ILA13.10 Million ≈ $35.11K |
-6.64% |
| 2016-12-31 | ILA14.03 Million ≈ $37.61K |
+18.61% |
| 2015-12-31 | ILA11.83 Million ≈ $31.71K |
-6.78% |
| 2014-12-31 | ILA12.69 Million ≈ $34.01K |
-5.20% |
| 2013-12-31 | ILA13.38 Million ≈ $35.88K |
+1.12% |
| 2012-12-31 | ILA13.23 Million ≈ $35.48K |
+83.87% |
| 2011-12-31 | ILA7.20 Million ≈ $19.30K |
-24.14% |
| 2010-12-31 | ILA9.49 Million ≈ $25.44K |
+1364.35% |
| 2009-12-31 | ILA648.00K ≈ $1.74K |
-49.96% |
| 2008-12-31 | ILA1.29 Million ≈ $3.47K |
-- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more